Abstract
Tumor progression and metastasis are complex processes involving intricate interplay among multiple gene products. Astrocyte elevated gene (AEG)-1 was cloned as an human immunodeficiency virus (HIV)-1-inducible and tumor necrosis factor-α (TNF-α)-inducible transcript in primary human fetal astrocytes (PHFA) by a rapid subtraction hybridization approach. AEG-1 down-regulates the expression of the glutamate transporter EAAT2; thus, it is implicated in glutamate-induced excitotoxic damage to neurons as evident in HIV-associated neurodegeneration. Interestingly, AEG-1 expression is elevated in subsets of breast cancer, glioblastoma multiforme and melanoma cells, and AEG-1 cooperates with Ha-ras to augment the transformed phenotype of normal immortal cells. Moreover, AEG-1 is overexpressed in > 95% of human malignant glioma samples when compared with normal human brain. Overexpression of AEG-1 increases and siRNA inhibition of AEG-1 decreases migration and invasion of human glioma cells, respectively. AEG-1 contains a lung-homing domain facilitating breast tumor metastasis to lungs. These findings indicate that AEG-1 might play a pivotal role in the pathogenesis, progression and metastasis of diverse cancers. Our recent observations indicate that AEG-1 exerts its effects by activating the nuclear factor kappa B (NF-κB) pathway and AEG-1 is a downstream target of Ha-ras and plays an important role in Ha-ras-mediated tumorigenesis. These provocative findings are intensifying interest in AEG-1 as a crucial regulator of tumor progression and metastasis and as a potential mediator of neurodegeneration. In this review, we discuss the cloning, structure and function(s) of AEG-1 and provide recent insights into the diverse actions and intriguing properties of this molecule.
Original language | English |
---|---|
Pages (from-to) | 155-170 |
Number of pages | 16 |
Journal | Pharmacology and Therapeutics |
Volume | 114 |
Issue number | 2 |
DOIs | |
Publication status | Published - May 2007 |
Bibliographical note
Funding Information:The present studies were supported in part by National Institutes of Health grants P01 NS31492 (DJV, PBF) and R01 CA35675 (PBF), the Samuel Waxman Cancer Research Foundation (PBF), the Chernow Endowment (PBF), a Joelle Syverson Fellowship from the American Brain Tumor Association (LE), and a grant from the Goldhirsh Foundation (DS).
Keywords
- AEG-1
- AEG-1 promoter
- Glutamate excitotoxicity
- Ha-ras oncogene
- Metastasis
- Progression